98%
921
2 minutes
20
Background: Although a rare complication, periprosthetic fractures (PPF) following total hip arthroplasty (THA) are becoming more common. Revision THA (rTHA) for PPF is associated with high failure rates, and there is a paucity of literature reporting how often there is a subsequent PPF in these patients. This study aimed to determine the rate of femoral re-fracture following rTHA in patients with an initial PPF after primary THA.
Methods: The retrospective study identified 2044 patients who underwent rTHA between 2017 and 2023. Propensity score-matched cohort analysis was conducted to control for demographic variables. The primary outcome was the re-fracture rate and survivability of those patients who were revised for PPF.
Results: There were 183 patients who sustained an initial PPF and underwent subsequent rTHA. Of these patients, five (2.7 %) sustained re-fracture of the femur. After matching, there was a 3.7 % re-fracture rate in patients revised for an initial PPF compared to those who were not revised for PPF (0.37 %, = 0.017). The 1-year re-fracture-free survivability of patients revised for initial PPF was 95.9 %, which was significantly lower compared to patients revised for non-PPF indications (99.6 %; = 0.008). Older patients, women, elevated Charlson Comorbidity Index (CCI), and posterior approach during rTHA were found to be risk factors for PPF ( < 0.001).
Conclusion: Patients who were revised for an initial PPF had nearly a 10 times increased risk of re-fracturing compared to patients revised for other indications in THA. However, the similar readmission and failure rates and 1-year implant survivorship suggest comparable outcomes. Further analysis with a larger cohort and more outcome events is necessary.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166759 | PMC |
http://dx.doi.org/10.1016/j.jor.2025.05.052 | DOI Listing |
Osteoporos Int
September 2025
National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin County, Taiwan.
Unlabelled: People with a hip fracture are prone to break the bone around the metal repair, causing severe health issues. This study found that initiating anti-osteoporotic medication soon after the first fracture halves that risk, highlighting the benefit of early osteoporosis treatment.
Background: Hip fractures pose significant clinical challenges, often leading to prolonged hospitalization, reduced quality of life, and increased risk of subsequent fractures.
Eur Respir Rev
June 2025
Respiratory Medicine Department, University of Patras, Patras, Greece.
Several interstitial lung diseases (ILDs) with different aetiologies and pathogenic mechanisms may exhibit a progressive behaviour, similar to idiopathic pulmonary fibrosis, with comparable functional decline and early mortality. Progressive pulmonary fibrosis (PPF) is not a diagnosis but rather reflects a clinical phenotype. Identifying progression is challenging as variability exists, both between different ILDs as well as in the context of the same entity.
View Article and Find Full Text PDFZhonghua Jie He He Hu Xi Za Zhi
August 2025
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin 300052, China.
Pancreaticopleural fistula (PPF) is a rare complication of chronic pancreatitis that is often overlooked in the initial differential diagnosis of pleural effusion, resulting in delays to diagnosis and treatment. This manuscript reported a case of a patient with recurrent hemorrhagic pleural effusion, in whom markedly elevated levels of amylase and lipase in the pleural fluid led to a diagnosis of pancreaticopleural fistula via magnetic resonance cholangiopancreatography (MRCP). This case aimed to raise awareness among clinicians about the importance of considering uncommon etiologies in the differential diagnosis of pleural effusion, and highlights the significance of elevated amylase levels in pleural fluid for the diagnosis of pancreaticopleural fistula.
View Article and Find Full Text PDFRespir Investig
September 2025
Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama-City, Kanagawa 236-0051, Japan.
Background: Transbronchial lung cryobiopsy (TBLC) is recommended as an alternative to surgical lung biopsy. However, the diagnostic accuracy of TBLC is lower than that of surgical biopsy, which occasionally necessitates re-evaluation of the initial treatment strategy following disease progression. The present retrospective study aimed to evaluate the diagnosis and/or treatment modifications following cryo-rebiopsy, as well as the safety of the procedure in patients with progressive interstitial lung disease (ILD).
View Article and Find Full Text PDFCureus
July 2025
Allergy and Immunology, David Tvildiani Medical University, Tbilisi, GEO.
Background The clinical course of patients with idiopathic pulmonary fibrosis (IPF) and other progressive interstitial lung diseases (F-ILDs) varies from mild to severe worsening, which makes the development of new diagnostic and prognostic methods even more urgent. A number of studies have shown that plasma connective tissue growth factor (CTGF) is elevated during IPF, and that the levels of this substance are correlated with the changes in forced vital capacity (FVC). The aim of our study was to investigate CTGF levels in patients with F-ILDs group, including its subgroups IPF and other F-ILDs, as well as post-COVID-19 cases, and to assess their association with lung function changes over a 12-month period.
View Article and Find Full Text PDF